Vaut-il la peine de vacciner contre SARS-CoV-2 les patients ayant reçu des thérapies anti-CD20 ? Oui, mais à certaines conditions.
Details
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_B443AF8994A7
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
Title
Vaut-il la peine de vacciner contre SARS-CoV-2 les patients ayant reçu des thérapies anti-CD20 ? Oui, mais à certaines conditions.
Journal
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
16/03/2022
Peer-reviewed
Oui
Volume
18
Number
773
Pages
499
Language
french
Notes
Publication types: News
Publication Status: ppublish
Publication Status: ppublish
Keywords
Antibodies, Viral, COVID-19, Humans, SARS-CoV-2
Pubmed
Create date
11/04/2022 9:49
Last modification date
11/11/2023 8:19
Usage data
